Certified Sites
FDA and EMEA approved sites
Boehringer Ingelheim manufacturing facilities are operating in strict compliance with current good manufacturing practices (cGMP). They are inspected and certified by the regulatory agencies across the globe (FDA, EMEA, MHRA, ANVISA, ASEAN etc.)
A high level of cGMP awareness
In addition to the inspections by the regulatory authorities, our facilities are subject to regular inspections from Boehringer Ingelheim corporate auditors, ensuring a continuous improvement and a high level of cGMP awareness. As company policy, we also commit to maintain the highest standards for environmental protection and safety.
Approved sites
| Facillities | Solids | Semi-solids | Liquids | Injectables |
|---|---|---|---|---|
| Bedford, Ohio, USA | - | - | - | FDA |
| Bogor, Indonesia | ASEAN | ASEAN | ASEAN | - |
| Bogota, Colombia | South America | South America | South America | - |
| Itapecerica, Brazil | EMEA, South America | - | EMEA, South America | - |
| Koropi, Greece | EMEA | - | - | - |
| Mexico City, Mexico | FDA, South America | South America | South America | - |
| Reggello, Italy | EMEA | EMEA | EMEA | - |
| Lugano, Switzerland | Swissmedic | EMEA | Swissmedic | - |